chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The patient did not disclose that she had a vaccine prior to signing up to our clinic.  We discovered the information when entering the vaccine information that was given to the patient on 3/11/2021. Contacted our local health department and was instructed to submit a VERS.
Swelling/erythema shoulder to below elbow of left arm where received DTaP.
excessive shaking, Body aching all over headache & exhaustion immediately for 3-4 days. Later(about 2 months later) continued exhaustion & Body aches. The Booster received on 1/10/22, (moderna Pharmacy administered. Lot # 016J21A) gave me same adverse reaction immediately following shot. Which lasted for 2 days. Incidentally I had Covid 19 -(suspected) in February, 2019. Loss of taste followed for several months. (It was at the very beginning of the pandemic)
MENTAL FOG; BODY PAIN AND BODY ACHES; FEVER OF 101; WEAKNESS; TERRIBLE HEADACHE; TIREDNESS; CHILLS; This spontaneous report received from a consumer concerned a 69 year old male. The patient's weight was 79.38 kilograms, and height was 180 centimeters. The patient's past medical history included had coronavirus prior to the shot, and concurrent conditions included emphysema. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802072 expiry: UNKNOWN) dose was not reported, administered on 13-MAR-2021 16:30 to the left upper arm in the muscle for prophylactic vaccination. No concomitant medications were reported. On JUN-2020, Laboratory data included: Coronavirus test (NR: not provided) negative (units unspecified). On 13-MAR-2021, the subject experienced chills. On 14-MAR-2021, the subject experienced body pain and body aches. On 14-MAR-2021, the subject experienced fever of 101. On 14-MAR-2021, the subject experienced weakness. On 14-MAR-2021, the subject experienced terrible headache. On 14-MAR-2021, the subject experienced tiredness. Laboratory data included: Body temperature (NR: not provided) 101. On an unspecified date, the subject experienced mental fog. Laboratory data (dates unspecified) included: Blood test (NR: not provided) excellent (units unspecified). Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body pain and body aches, chills, and fever of 101 on 16-MAR-2021, and weakness, and terrible headache on 15-MAR-2021, was recovering from tiredness, and had not recovered from mental fog. This report was non-serious.; Sender's Comments: V0: Medical assessment comment is not required as per standard procedure as case assessed as non-serious.
Pt had vaccines on 3/9 approximately 1:30 pm. Approx 5.00 her right arm & right trunk had welts. Gave Benadryl & helped. Next day, welts still on right arm. On 3/12, pt had hives on right elbow & right hand went numb for a little bit. * Pt had dental work on same side on same day*
I am having intermittent throbbing and tingling at injection site and it is sore to touch
(L) upper arm with swelling, warmth & pinkness around periphery of injection.
Pt felt sick with back pain and diarrhea for about 5 days after the first Covid Moderna vaccine on 4/1/21. She got better and received the 2nd dose on 4/29/21. She developed bad joint pain and poor appetite with progressively worse symptoms including shortness of breath, chills, unable to stand up, felt weak, low grade fever, inanition, diarrhea. Work up in late May revealed new diffuse centrilobular ground glass opacities and numerous solid pulmonary nodules. Transbronchial lung biopsy revealed perivascular lymphocytes, but was non-diagnostic. No new treatment was given and follow up chest CT cleared up over a few months and she recovered.
WHEN I WOKE UP NEXT MORNING I HAD SEVERE PAIN IN ARM WHERE I GOT FLU SHOT, SEVERE CRAMPS IN ENTIRE ARM SHOULDER BLADE HAND PINS AND NEEDLES IN FINGERS WEAKNESS IN ARM IT HAS BEEN 13 DAYS AND STILL FINGERS ARE NUMB SHOOTING PAINS DOWN ARM FOREARM FEELS LIKE IT IS BURNING.
This spontaneous report as received from a pharmacist via a company representative refers to a 81 year old female patient. Medical history was not provided. On an unknown date in the recent past the patient was vaccinated with ZOSTAVAX (route of administration was not provided, lot H1021459 (determined to be not valid). No information on concomitant medications was reported. On an unknown date the patient experienced "developed a red arm". The patient's arm was not sore, did not itch and the patient was fine now. No treatment was provided. The red arm lasted one week and then went away. The outcome of patient developed a red arm was recovered/resolved. No action taken with ZOSTAVAX was provided. Additional information has been requested.
inflamed rt arm about 3 1/2-4inches in diameter;was very warm to touch & sore;began 24hrs p/vax lasted 4 days
This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. No information about the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant therapies was provided. On 17-JAN-2017 at 10:41, the patient was vaccinated with an improperly stored VARIVAX (lot # M031969) for prophylaxis (expiration date, dose and route of administration were not reported). It was reported that the vaccine underwent previous temperature excursions, but the number of previous excursions, time frames and values of incorrect temperature were unknown. A digital data logger was used. No adverse effects were reported. Product quality complaint was not involved. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1701USA008441: US-009507513-1704USA000389: US-009507513-1704USA000390: US-009507513-1704USA000391: US-009507513-1704USA000392: US-009507513-1704USA000393: US-009507513-1704USA000394: US-009507513-1704USA000395: US-009507513-1704USA000396: US-009507513-1704USA000397: US-009507513-1704USA000398: US-009507513-1704USA000399: US-009507513-1704USA000400: US-009507513-1704USA000401: US-009507513-1704USA000402: US-009507513-1704USA000403: US-009507513-1704USA000404: US-009507513-1704USA000405: US-009507513-1704USA000406: US-009507513-1704USA000407: US-009507513-1704USA000408: US-009507513-1704USA000409: US-009507513-1704USA000410: US-009507513-1704USA000411: US-009507513-1704USA000412: US-009507513-1704USA000413: US-009507513-1704USA000414: US-009507513-1704USA000415: US-009507513-1704USA000416: US-009507513-1704USA000417: US-009507513-1704USA000418: US-009507513-1704USA000419: US-009507513-1704USA000420: US-009507513-1704USA000421: US-009507513-1704USA000422: US-009507513-1704USA000423: US-009507513-1704USA000424: US-009507513-1704USA000425: US-009507513-1704USA000426: US-009507513-1704USA000427: US-009507513-1704USA000428: US-009507513-1704USA000429: US-009507513-1704USA000430: US-009507513-1704USA000431: US-009507513-1704USA000432: US-009507513-1704USA000433: US-009507513-1704USA000434: US-009507513-1704USA000435: US-009507513-1704USA000436: US-009507513-1704USA000437: US-009507513-1704USA000439: US-009507513-1704USA000440: US-009507513-1704USA000441: US-009507513-1704USA000442: US-009507513-1704USA000443: US-009507513-1704USA000444: US-009507513-1704USA000445: US-009507513-1704USA000446: US-009507513-1704USA000447: US-009507513-1704USA000448: US-009507513-1704USA000449: US-009507513-1704USA000450: US-009507513-1704USA000451: US-009507513-1704USA000452: US-009507513-1704USA000453: US-009507513-1704USA000454: US-009507513-1704USA000455: US-009507513-1704USA000456: US-009507513-1704USA000457.
Lymphoma; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHOMA (Lymphoma) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHOMA (Lymphoma) (seriousness criterion medically significant). At the time of the report, LYMPHOMA (Lymphoma) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication not reported.  Treatment medication not reported.  Company comment: Based on reporter's causality (Lymphoma caused by Covid-19 vaccine) the event is assessed as unlikely related to mRNA-1273.; Sender's Comments: Based on reporter's causality (Lymphoma caused by Covid-19 vaccine) the event is assessed as unlikely related to mRNA-1273.
Moderna COVID-19 Vaccine EUA Patient received the Moderna Covid vaccine and 5 minutes after this began to have the sensation of tongue swelling and nausea.  She was given epinephrine and Benadryl IM prior to arrival at the emergency department.  Upon arrival at ED, she states that she feels a little odd, but is otherwise back to baseline.  Denies any difficulty breathing, lightheadedness, abdominal pain, nausea, or diarrhea.  States this feels similar to her prior reactions to shellfish. In the emergency department patient given dexamethasone given concern for anaphylactic reaction.  Patient was observed for several hours with no worsening of symptoms.  She was discharged home in stable condition.
Patient voices that she has developed a localized, raised rash at the injection site that runs from the top of her shoulder to the elbow, denies blistering, heat, or itching. Denies fever.
On 4th day I began urinating blood.   Was diagnosed with a secondary infection of the left kidney, bladder and testicle (orchitis and epidymitis). It was antibiotic resistant until 3 week course of ciproflovaxin.  Still ongoing.   Ever since, blood pressure and HR wont regulate - shifts between 150/110 and 100/60 bp and 50-90HR every 15min.    Uncontrollable anxiety.  All of my veins are bursting, legs are blue and purple
pt recv vax 24OCT96 & w/in 24hr of vax pt arm had turned black & blue from shoulder to elbow, the inside of mouth became swollen & cracked & fingers became swollen & red @ tips;
I started getting symptoms of headache, sore throat, and slight fever. I took a COVID-19 home test that was positive. I went to a clinic and had a positive COVID-19 test. I also developed nausea. I contacted my doctor and was prescribed Paxlovid. I feel like the Paxlovid helped and within a 2 days, I was feeling much better. I still have a slight cough but I do have COPD.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 64-year-old female patient who received SHINGRIX (batch number X5XY4, expiry date 28th February 2020) for prophylaxis. Previously administered products included SHINGRIX (1st dose received on an unknown date). Concomitant products included ARANESP. On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site erythema, injection site swelling, myalgia, feeling bad and injection site pain. On an unknown date, the outcome of the injection site erythema, injection site swelling, myalgia, feeling bad and injection site pain were unknown. It was unknown if the reporter considered the injection site erythema, injection site swelling, myalgia, feeling bad and injection site pain to be related to SHINGRIX. Additional details were provided as follows: The patient was to start a new therapy with ARANESP. This new therapy was for a condition that was reported after the patient had completed the 2 dose SHINGRIX schedule. The patient was presented with myalgia. The patient also reported pain, redness and swollen at injection site. The patient also reported felling terrible after receiving SHINGRIX to her pharmacist. The pharmacist was unsure which were had the injection site reaction. The pharmacist was unsure if the condition was related. The pharmacist was not familiar with the patient and took the information over the phone while the patient was trying to get the ARANESP. No additional details were provided.
At 11:10 am, I came home after getting the flu shot, which was at 10:50 am. I felt light-headed and my face and lips turned pale. I had to lie on the floor and take deep breaths from passing out. I had to use the restroom, so I crawled towards the restroom and turned more pale and dry heaved. My heart rate slowed down dramatically and so did my temperature. I became weak, shaky, sweaty, and freezing cold. I had side pain while still in the restroom as well. This lasted for 10 minutes. After, I soon became better and gained color back in my face as well as my temperature. I reported what happened 10 minutes after my reaction to Primary Health to report this and to keep on my record.
Pt received vaccine 06-4-13, was out of town 7-5-13 - 7-7-13. On 7-8-12 9 y/o grandson has mild case of chicken pox. He had received vaccine at age 1. 7-23-13 pt broke out with rash on thighs, buttock, stomach. Approx 100 lesions. Also, 10 m/o grandson broke out on 7-29-13.
Patient states ''I received a COVID vaccine yesterday''. Shot was given yesterday at 2:30 pm. Patient states allergic reaction started 10-15 minutes after shot was given. Patient states her eyes are itching and red. Patient states redness around her eyes and legs. RN triaged patient and recommended patient to go to ED now. Patient states she is going to wait and see if she feels better. Denies difficulty breathing or difficulty to swallow.
Moderna vaccine was administered outside of Facility- reported by patient  I63.9 ACUTE STROKE DUE TO OCCLUSION OF UNSPECIFIED ARTERY 8/6/2021 LATE EFFECT OF STROKE I63.9 ACUTE STROKE DUE TO OCCLUSION OF UNSPECIFIED ARTERY 8/6/2021 ALTERED MENTAL STATUS, UNSPECIFIED
No additional AE information provided; the patient was administered an improperly stored dose of VAQTA; This initial spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. This report concerns one patient and one combination product.  On 26-MAY-2020, the patient was vaccinated with an improperly stored dose of hepatitis a vaccine, inactivated (VAQTA) lot # S032055, expiration date: 09-NOV-2020 (exact dose, injection site and route of administration were not provided) for prophylaxis. The administered vaccine experienced a temperature excursion of 12.1 degrees Celsius for 16 hours and 11 minutes. The digital data logger was involved in regards the temperature excursion details. No previous temperature excursion had occurred. No additional adverse event information was provided. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; manufactureraddress:; manufacturercity:; manufacturerstate:; manufacturercountry:; devicelotnumber: S032055; expirationdate: 09-NOV-2020; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
Information has been received from a 64 year old female registered dental hygienist with osteopenia and an allergy to an unspecified antibiotic that " started with a C" who on 13-MAR-2007 was vaccinated with a 0.65 ml dose of Zostavax. Concomitant therapy included risedronate sodium (ACTONEL). On 17-MAR-2007 four days after vaccination, the patient developed red itchy patches on her arm. A few days later her stomach started itching but she did not have any visible rash on her stomach. She stated that she did not have any break through varicella-like lesions. No medical attention was sought and no diagnostic laboratory tests were performed. At the time of the report, the patient had not recovered. Additional information has been requested.
widwly spread reaction in the arm up to the elbow; wide spread reaction at the injection site, redness and itching of the arm; wide spread reaction at the injection site, redness and itching of the arm; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE ERYTHEMA (wide spread reaction at the injection site, redness and itching of the arm), VACCINATION SITE PRURITUS (wide spread reaction at the injection site, redness and itching of the arm) and ADVERSE REACTION (widwly spread reaction in the arm up to the elbow) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Low blood pressure. Concomitant products included LISINOPRIL for an unknown indication.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (wide spread reaction at the injection site, redness and itching of the arm) and VACCINATION SITE PRURITUS (wide spread reaction at the injection site, redness and itching of the arm). On 17-Jan-2021, the patient experienced ADVERSE REACTION (widwly spread reaction in the arm up to the elbow). At the time of the report, VACCINATION SITE ERYTHEMA (wide spread reaction at the injection site, redness and itching of the arm), VACCINATION SITE PRURITUS (wide spread reaction at the injection site, redness and itching of the arm) and ADVERSE REACTION (widwly spread reaction in the arm up to the elbow) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment drug included Tylenol and benadryl; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events,   a causal relationship cannot be excluded.
Information has been received from a registered nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies and concomitant medication were not provided. On an unknown date, the patient was administered a dose of PROQUAD (rHA, lot # M004889, expiration date 25-JUL-2017, intramuscular; dose was unknown). This was outside the recommendations per the PROQUAD prescribing information. No adverse effects was reported. Additional information is not expected as there was no consent to contact the reporter.
almost passed away; blood clot in her heart; getting real sick; She was in terrible pain; This is a spontaneous report from a contactable consumer. This female consumer (patient) reported for herself that:  A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown), dose 2 via an unspecified route of administration on May2021 at dose 2, single for covid-19 immunisation. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration on Apr2021 at dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in 2021, patient was getting real sick and almost passed away, patient had a blood clot in her heart. She was out for 4 to 5 weeks. Patient was in the hospital for 9 days. Patient had a CT scan and that is how the blood clot was found since she did not know. Patient was in terrible pain. Now she is on blood thinners. Patient never had a blood clot or was on blood thinners before the shot. Patient does not know what is going on and is asking about compensation. She had both doses. The patient underwent lab tests and procedures which included computerised tomogram: blood clot was found on an unspecified date in 2021. Therapeutic measures were taken as a result of blood clot in her heart. At the time of reporting, the outcome of the events were unknown.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
I got a really bad pain on my right pelvic side that lasted about 10 days before the pain disappeared. I took aspirin. I went to my PCP and the doctor did an X-ray a month later. On April 11, I became really dizzy and vomited. I took motion sickness pills, Bonine, and it lasted two days.
On 1/15/2021 at about 930, I began to to feel an itch on my stomach.  I lifted my shirt and noticed Petechia on my stomach, as well as my arms and a little on my back.  I had no fever, no sore throat. Fatigue and chills I had on the night of the 15th and continues on and off.   I phoned the PCP on 1/16/2021 on call for DR to describe my rash.  MD ordered Covid test, that was done on the 15 th and and came back neg.  I do have body aches
This spontaneous case reported by an other healthcare professional, describes the occurrence of vaccination site movement impairment (could not move arm after receiving the vaccine) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced vaccination site movement impairment (could not move arm after receiving the vaccine). At the time of the report, vaccination site movement impairment (could not move arm after receiving the vaccine): unresolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. The reporter did not provide any causality assessments or concomitant medications. The patient is currently on physical therapy. Sender's comments: Based on the current available information, which includes a temporal association between the use of the product and the start date of the reported events, and excluding any other etiology, a causal relationship with the event cannot be excluded.
The pt developed swelling and erythema 11-12cm below vaccine site 3-4 hours after injection. Ice was applied and then the swelling was down slightly.
Injection in left shoulder, extremely painful, got worse as time went on, arm became very swollen from shoulder to elbow, hot to the touch. I started to feel very sick, weak, all joints were very painful all over my body. I got worse at night from 9:00pm on through the night I felt that I could hardly move in the bed. It took a long time and great pain to slide off bed and make it to toilet and back. I arm could hardly move. I could not sleep. By 5:00am I made myself get up with great effort and slowly got to kitchen for water. I went back to bed and stayed til mid morning and got up again....got to kitchen (extremely small apt, not far from bed to kitchen). Got water and made myself get part of banana. Stayed in bed til night at which time I started to get strength in my legs.  Had to put arm in sling that I had because I could not lift my are from pain. Got better at night but was very weak and arm was still very painful and swollen and flesh felt "lumpy". Getting better and eating light food.
I was putting my son to sleep and I fell asleep for about 10 minutes. When I woke up my vision I was unable to see clearly from my right eye. It was extremely blurry. It lasted for about 2-3 hours at which point I went to sleep. When I woke up the next morning my vision was completely restored.